RNA Aptamer-targeted Inhibition of NF-κB Suppresses Non-small Cell Lung Cancer Resistance to Doxorubicin-Reference-Cited by-同舟云学术

RNA Aptamer-targeted Inhibition of NF-κB Suppresses Non-small Cell Lung Cancer Resistance to Doxorubicin

Published:2008-01 Issue:1 Volume:16 Page:66-73
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Mi Jing,Zhang Xiuwu,Rabbani Zahid N,Liu Yingmiao,Reddy Srinevas K,Su Zhen,Salahuddin Fawzia K,Viles Kristi,Giangrande Paloma H,Dewhirst Mark W,Sullenger Bruce A,Kontos Christopher D,Clary Bryan M

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference43 articles.

1. Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines;Bilyeu;Mol Pharmacol,2004

2. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs;Nakanishi;Nat Rev Cancer,2005

3. The NF-kappaB and IkappaB proteins: new discoveries and insights;Baldwin;Annu Rev Immunol,1996

4. NF-kappaB in cancer: a marked target;Lin;Semin Cancer Biol,2003

5. Apoptosis: a link between cancer genetics and chemotherapy;Johnstone;Cell,2002

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic anticancer effects of omega-3 fatty acids (EPA/DHA) and anticancer drug Doxorubicin against human lung adenocarcinoma;Food Bioscience;2024-10

2. Engineering artificial non-coding RNAs for targeted protein degradation;Nature Chemical Biology;2024-08-30

3. Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics;Journal of Chemotherapy;2024-08-05

4. Synergestic Cytotoxicity of Doxorubicin in Combination with Epigallocatechin 3-gallate in Non-Small Cell Lung Cancer by Inhibiting Protein Vimentin;International Journal of Pharmaceutical Investigation;2024-04-02

5. OGG1 as an Epigenetic Reader Affects NFκB: What This Means for Cancer;Cancers;2023-12-28